RecallHawk
Class II Recall

IMPIX MANTA+, REF numbers: a) B20171743, b) B20171753, c) B20171763, d) B20171773, e) B20171943, f) B201719

Medicrea International

Summary

The FDA issued a Class II for IMPIX MANTA+, REF numbers: a) B20171743, b) B20171753, c) B20171763, d) by Medicrea International. Reason: There is a potential for a product packaging non-conformity issue which presents as a pinhole in either the inner or outer pouch..

Details

Source

Device Recall

External ID

Z-2462-2023

Action Date

2023-08-30

Status

Ongoing

Category

device

Product Description

IMPIX MANTA+, REF numbers: a) B20171743, b) B20171753, c) B20171763, d) B20171773, e) B20171943, f) B20171953, g) B20171963, h) B20171973, i) B20172253, j) B20172263, k) B20172273; intervertebral fusion device - cervical

Lot/Code Info: a) B20171743, GTIN 03613720232636, Lot Numbers: 18E0275, 18E0404, 18E0676, 18E0833, 18I0867, 18K0143, 18L0219, 19A0463, 19A0669, 19B0870, 19D0484, 19G0192, 19G0422, 19J0468, 19L0381, 20F0631, 20G0849, 20H0596, 20H0597, 20H0598, 20I0875, 20J0772, 21I0163, 22A0172, 22D0807, 22E0264, 22G0048, 22G0477, 22I0342; b) B20171753, GTIN 03613720232667, Lot Numbers: 18H0597, 18K0137, 18K0831, 18L0488, 19A0324, 19A0325, 19B0362, 19B0470, 19D0485, 19E0322, 19G0204, 19G0423, 19I0274, 19J0273, 19L0382, 20F0632, 20F0633, 20H0600, 20H0601, 20H0602, 20H0603, 20I0222, 21C0104, 21F0651, 21I0511, 22I0615, 22J0265; c) B20171763, GTIN 03613720232698, Lot Numbers: 18E0405, 18E0834, 18G0422, 18H0572, 18J0063, 18K0066, 18L0070, 18L0489, 19A0215, 19A0425, 19B0687, 19C0653, 19D0486, 19E0436, 19G0830, 19I0842, 19L0383, 20F0634, 20H0594, 20H0595, 21E0234, 21G0482, 22I0343; d) B20171773, GTIN 03613720232728, Lot Numbers: 19C0591, 19F0579, 19H0089, 19J0272, 20F0635, 20H0249, 22G0571; e) B20171943, GTIN 03613720232841, Lot Numbers: 18C0552, 18E0835, 18I0712, 18K0897, 18L0490, 19A0670, 19B0680, 19D0251, 19G0302, 19I0582, 20A0644, 20F0636, 20H0599, 20I0487, 21H0101, 22A0173, 22B0482, 22D0808, 22E0808; f) B20171953, GTIN 03613720232872, Lot Numbers: 18E0483, 18E0677, 18E0836, 18J0103, 18K0144, 18L0400, 19A0159, 19A0671, 19A0675, 19B0089, 19D0487, 19D0637, 19F0103, 19G0303, 19H0375, 19I0843, 19K0586, 20A0200, 20C0163, 20F0637, 20H0251, 20H0254, 20H0255, 20J0062, 20J0065, 20J0368, 21F0551, 21I0177, 22B0786, 22E0263, 22E0809, 22F0490, 22F0492, 22G0440, 22H0055, 22J0202; g) B20171963, GTIN 03613720232902, Lot Numbers: 18K0158, 18L0491, 19A0672, 19A0829, 19C0146, 19D0262, 19E0437, 19G0424, 19H0376, 19I0234, 19K0832, 19L0613, 20A0969, 20F0638, 20H0604, 20H0605, 20H0606, 20H0607, 20I0705, 20J0068, 21F0155, 22D0809, 22G0441, 22H0643, 22J0203,; h) B20171973, GTIN 03613720232933, Lot Numbers: 18D0171, 18F0203, 18I0466, 18K0136, 18L0492, 19A0673, 19D0488, 19I0844, 20H0257, 21A0064, 22D0385, 22F1090, 22G0442; i) B20172253, GTIN 03613720233084, Lot Numbers: 18E0406, 18K0140, 18K0898, 19A0214, 19B0174, 19C0728, 19E0438, 19I0583, 20H0258, 20K0542, 21G0760; j) B20172263, GTIN 03613720233114, Lot Numbers: 18D1078, 18G0423, 18K0159, 18L0220, 19A0069, 19B0175, 19E0439, 19I0845, 20A0995, 20F0386, 20H0593, 20J0127, 21F0247, 21J0503; k) B20172273, GTIN 03613720233145, Lot Numbers: 18K0160, 18K0608, 19A0079, 19B0471, 19C0729, 19D0671, 19J0469, 20H0259, 22B0180, 22B0484, 22E0095

Quantity Affected: N/A

Reason for Recall

There is a potential for a product packaging non-conformity issue which presents as a pinhole in either the inner or outer pouch.

Distribution

US nationwide

Type: Voluntary: Firm initiated

Recall Initiated: 2023-07-12

Company

Medicrea International

Rillieux La Pape, N/A

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 152 device recalls issued in the same week, part of 403 device-related FDA actions this month.

Medicrea International has 16 FDA actions in our database, including 14 recalls and 2 clearances.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Medicrea International) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Medicrea International have FDA actions?

Medicrea International has 16 FDA actions in our database, including 14 recalls and 2 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-2462-2023" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions